Accepted for Publication: July 23, 2021.
Published: September 30, 2021. doi:10.1001/jamanetworkopen.2021.27582
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Carson SL et al. JAMA Network Open.
Corresponding Author: Savanna L. Carson, PhD, Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 1100 Glendon, Ste 1820, Los Angeles, CA 90095 (scarson@mednet.ucla.edu).
Author Contributions: Dr Carson had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Carson, Casillas, Castellon-Lopez, Morris, Barron, Ntekume, Vassar, Norris, Dubinett, Garrison, Brown.
Acquisition, analysis, or interpretation of data: Carson, Casillas, Castellon-Lopez, Mansfield, Barron, Ntekume, Landovitz, Vassar, Garrison, Brown.
Drafting of the manuscript: Carson, Casillas, Castellon-Lopez, Mansfield, Morris, Ntekume, Vassar, Garrison, Brown.
Critical revision of the manuscript for important intellectual content: Carson, Casillas, Castellon-Lopez, Mansfield, Barron, Ntekume, Landovitz, Vassar, Norris, Dubinett, Garrison.
Statistical analysis: Carson, Mansfield.
Obtained funding: Carson, Vassar, Norris, Dubinett, Brown.
Administrative, technical, or material support: Carson, Casillas, Castellon-Lopez, Mansfield, Morris, Barron, Ntekume, Vassar, Garrison, Brown.
Supervision: Carson, Casillas, Landovitz, Vassar, Norris, Brown.
Conflict of Interest Disclosures: Drs Carson, Brown, Morris, Castellon, Casillas, and Garrison and Ms Vassar reported receiving grants from the National Heart, Lung, and Blood Institute, the National Center for Advancing Translational Science, and the UCLA Oversight COVID-19 Research Committee during the conduct of the study. Dr Ntekume reported receiving grants from the National Heart, Lung, and Blood Institute, the National Center for Advancing Translational Science, and the UCLA Oversight COVID-19 Research Committee during the conduct of the study. Dr Landovitz reported receiving grants from the National Institutes of Health during the conduct of the study and personal fees from Gilead Sciences, Merck Inc, Roche, and Janssen outside the submitted work. Dr Norris reported receiving grants from the National Heart, Lung, and Blood Institute during the conduct of the study and grants from National Center for Advancing Translational Science, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases National Institute of General Medical Sciences, and National Institute on Minority Health and Health Disparities outside the submitted work. No other disclosures were reported.
Funding/Support: This research is supported by grant 21-312-0217571-66106L from CEAL/STOP COVID-19 CA, grant UL1TR001881 from the National Center for Advancing Translational Science, and grant OCRC 20-51 from UCLA.
Role of the Funder/Sponsor: The supporters of this study had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: The study participants, our Community Advisory Board, the UCLA Community Consultants Panel, and our community partners supported recruitment or provided feedback on preliminary results. We thank the diverse communities we come from and are embedded within that shape, influence, and guide our research approach in culturally congruent ways.
6.Bogart
LM , Ojikutu
BO , Tyagi
K ,
et al. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among Black Americans living with HIV.
J Acquir Immune Defic Synd. 2021;86(2):200-2007. doi:
10.1097/QAI.0000000000002570
7.Savoia
E , Piltch-Loeb
R , Goldberg
B ,
et al. Predictors of COVID-19 vaccine hesitancy: socio-demographics, co-morbidity and past experience of racial discrimination. medRxiv. Preprint posted online January 13, 2021. 2021.
12.Caserotti
M , Girardi
P , Rubaltelli
E , Tasso
A , Lotto
L , Gavaruzzi
T . Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents.
Soc Sci Med. 2021;272:113688. doi:
10.1016/j.socscimed.2021.113688 14.Salmon
D , Opel
DJ , Dudley
MZ , Brewer
J , Breiman
R . Reflections On governance, communication, and equity: challenges and opportunities in COVID-19 vaccination.
Health Aff (Millwood). 2021;40(3):419-425. doi:
10.1377/hlthaff.2020.02254 18.Carson
SL , Gonzalez
C , Lopez
S ,
et al. Reflections on the importance of community-partnered research strategies for health equity in the era of COVID-19.
J Health Care Poor Underserved. 2020;31(4):1515-1519. doi:
10.1353/hpu.2020.0112
PubMedGoogle ScholarCrossref 23.Archibald
MM , Ambagtsheer
RC , Casey
MG , Lawless
M . Using Zoom videoconferencing for qualitative data collection: perceptions and experiences of researchers and participants.
Int J Qual Methods. 2019;18:1609406919874596. doi:
10.1177/1609406919874596
Google Scholar 27.Mehta
P , Sharma
M , Lee
RC . Using the health belief model in qualitative focus groups to identify HPV vaccine acceptability in college men.
Int Q Community Health Educ. 2012-2013;33(2):175-187. doi:
10.2190/IQ.33.2.f
PubMedGoogle ScholarCrossref 29.Kobetz
E , Menard
J , Hazan
G ,
et al. Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability.
Educ Health (Abingdon). 2011;24(3):479.
PubMedGoogle Scholar 32.Braun
V , Clarke
V , Hayfield
N , Terry
G. Thematic analysis. In: Liamputtong
P , ed.
Handbook of Research Methods in Health Social Sciences. Springer Singapore; 2019:843-860. doi:
10.1007/978-981-10-5251-4_103
34.World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy. World Health Organization; 2014.
35.World Health Organization. Appendices to the Report of the SAGE Working Group on Vaccine Hesitancy. World Health Organization Strategic Advisory Group of Experts on Immunization Working Group; October 1, 2014.
38.World Health Organization. Data for action: achieving high uptake of COVID-19 vaccines: gathering and using data on the behavioural and social drivers of vaccination: a guidebook for immunization programmes and implementing partners: interim guidance, 1 April 2021. World Health Organization; 2021. Accessed July 9, 2021.
https://apps.who.int/iris/handle/10665/339452 46.Galbraith
KV , Lechuga
J , Jenerette
CM , Moore
LA , Palmer
MH , Hamilton
JB . Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: A literature review.
Soc Sci Med. 2016;159:116-126. doi:
10.1016/j.socscimed.2016.04.028
PubMedGoogle ScholarCrossref 48.Center
KE , Da Silva
J , Hernandez
AL ,
et al. Multidisciplinary community-based investigation of a COVID-19 outbreak among Marshallese and Hispanic/Latino communities—Benton and Washington Counties, Arkansas, March-June 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(48):1807-1811. doi:
10.15585/mmwr.mm6948a2
PubMedGoogle ScholarCrossref 50.Quinn
SC , Jamison
A , Freimuth
VS , An
J , Hancock
GR , Musa
D . Exploring racial influences on flu vaccine attitudes and behavior: results of a national survey of White and African American adults.
Vaccine. 2017;35(8):1167-1174. doi:
10.1016/j.vaccine.2016.12.046
PubMedGoogle ScholarCrossref 55.Momplaisir
F , Haynes
N , Nkwihoreze
H , Nelson
M , Werner
RM , Jemmott
J . Understanding drivers of COVID-19 vaccine hesitancy among Blacks.
Clin Infect Dis. 2021;ciab102. doi:
10.1093/cid/ciab102
PubMedGoogle Scholar 58.Oluyomi
AO , Gunter
SM , Leining
LM , Murray
KO , Amos
C . COVID-19 community incidence and associated neighborhood-level characteristics in Houston, Texas, USA.
Int J Environ Res Public Health. 2021;18(4):1495. doi:
10.3390/ijerph18041495
PubMedGoogle ScholarCrossref 62.National Institutes of Health. NIH Community Engagement Alliance (CEAL). National Institutes of Health. Published 2021. Accessed March 26, 2021.
https://covid19community.nih.gov